6-K 1 fresenius_6k.htm FORM 6-K Unassociated Document
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
 
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 
For the month of January 2011
 
FRESENIUS MEDICAL CARE AG & Co. KGaA
(Translation of registrant’s name into English)
 
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
 
    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
    Form 20-F x                                                                Form 40-F o
 
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
 
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
 
    Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
    Yes o                                                                            No x
 
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82
 
 
 

 

On January 4, 2011 Fresenius Medical Care AG & Co. KGaA (the “Company”) issued an Investor News announcing the signing of a purchase agreement to acquire International Dialysis Centers.

 
EXHIBITS
 
Exhibit 99.1
Investor News Release issued January 4, 2011.
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
DATE: January 4, 2011
 
 
Fresenius Medical Care AG & Co. KGaA,
a partnership limited by shares, represented by:
     
 
fresenius medical care management ag, its general partner
     
 
By:
/s/ Dr. Ben J. Lipps
    Name:
Dr. Ben J. Lipps
    Title:
Chief Executive Officer and Chairman of the Management Board of the General Partner
     
 
By:
/s/ Michael Brosnan
    Name:
Michael Brosnan
    Title:
Chief Financial Officer and Member of the Management Board of the General Partner